Takuma Matsumoto
Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Development and exploratory evaluation of a prediction model for oral mucositis in patients receiving CapeOX chemotherapy: a multicenter retrospective study.
Journal: Scientific reports
Published: April 24, 2026
Association Between Brachytherapy and Acute Diarrhea During Chemoradiotherapy for Cervical Cancer: A Multicenter Retrospective Study.
Journal: Anticancer research
Published: April 11, 2026
A Retrospective Multicenter Study to Examine the Risk Factors for Febrile Neutropenia during Amrubicin Hydrochloride Therapy for Recurrent Small Cell Lung Cancer
Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan
Published: April 01, 2026
Olanzapine Use and Vomiting Incidence in Chemotherapy-receiving Patients With Cervical Cancer: Multicenter Post Hoc Analysis.
Journal: In vivo (Athens, Greece)
Published: March 01, 2026
Detection of cyclophosphamide residues on community pharmacy counters: An exploratory survey.
Journal: The International journal of risk & safety in medicine
Published: December 26, 2025
Diuretic Administration for Vomiting During Concurrent Chemoradiotherapy for Cervical Cancer: A Multicenter Retrospective Study.
Journal: Anticancer research
Published: December 22, 2025
Psychometric properties, validation, and reliability of the Japanese version of the sport anxiety scale-2 for university student athletes.
Journal: Frontiers in psychology
Published: September 26, 2025
Development and validation of predictive model for emesis in cervical cancer patients receiving concurrent chemoradiotherapy based on multi-institutional retrospective study.
Journal: Scientific reports
Published: June 09, 2025
Timing of Naldemedine Initiation and Occurrence of Diarrhea in Patients Receiving Strong Opioid Analgesics: A Retrospective Study.
Journal: Pharmacy (Basel, Switzerland)
Published: February 21, 2025
A multicenter, phase II trial of triplet antiemetic therapy with palonosetron, aprepitant, and olanzapine for highly emetogenic chemotherapy in breast cancer (PATROL-II).
Journal: Scientific reports
Published: July 31, 2024
A multicenter phase II trial of the triplet antiemetic therapy with palonosetron, aprepitant, and olanzapine for a cisplatin-containing regimen. - PATROL-I.
Journal: Investigational new drugs
Published: October 17, 2023
Mechanism by which a LINE protein recognizes its 3' tail RNA.
Journal: Nucleic acids research
Published: August 22, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026